| Literature DB >> 28748204 |
Evelina Rekuviene1,2, Laima Ivanoviene1,2, Vilmante Borutaite1, Ramune Morkuniene1.
Abstract
The data presented in this article are related to the research article entitled "Rotenone decreases ischemia-induced injury by inhibiting mitochondrial permeability transition in mature brains" (Rekuviene et al., 2017) [1]. Data in this article present the direct effects of rotenone on calcium retention capacity (CRC) in isolated normal cortex and cerebellum mitochondria, effects of rotenone intravenous infusion on leak and phosphorylating respiration rates of isolated cortex and cerebellum mitochondria, on activities of respiratory chain complexes I and II in freezed-thawed/sonicated cortex and cerebellum mitochondria after brain ischemia. In addition, detailed experimental procedures of isolation of brain mitochondria, measurements of CRC, respiration, activities of respiratory chain complexes and H2O2 generation in cortex and cerebellum mitochondria are described.Entities:
Keywords: Brain ischemia; Calcium retention capacity; Complex I; Mitochondria; Respiration; Rotenone
Year: 2017 PMID: 28748204 PMCID: PMC5512184 DOI: 10.1016/j.dib.2017.06.052
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Direct effect of rotenone on CRC of isolated cortex (A) and cerebellum (B) mitochondria ** – p<0.01, * – p<0.05, if compared to control. Means±standard errors of 4–7 separate experiments are presented.
Effect of rotenone intravenous infusion on respiration of control and ischemia damaged cortex and cerebellum mitochondria. Rates of oxygen consumption are expressed in pmol O/s/mg mitochondrial protein. VLeak – mitochondrial leak respiration in the presence of pyruvate/malate (1/1 mM) and mitochondria (0.25 mg/ml); VADP – mitochondrial phosphorylating respiration with ADP (2 mM) and indicated substrate (either pyruvate/malate or succinate/amytal); VAtr – atractyloside inhibited respiration in the presence of succinate (5 mM) and amytal (1.5 mM). *** – p<0.001, ** – p<0.01, * – p<0.05, if compared to control; # – p<0.05, if compared to 120 min ischemia group. Means±standard errors of 3–7 separate experiments are presented.
| Control | Rot Control | Ischemia | Rot+Ischemia | |
|---|---|---|---|---|
| VLeak | 199.1±14.2 | 154.05±9.33 | 78.6±4.7 | 121.45±20.25 |
| VADP | 851.0±45.1 | 573.66±84.58 | 132.9±19.0 | 181.54±31.18 |
| VADP | 530.7±29.3 | 525.29±29.56 | 107.0±8.0 | 173.49±31.25 |
| VAtr | 301.1±9.4 | 330.08±30.43 | 126.5±18.7 | 163.98±35.31 |
| Control | Rot Control | Ischemia | Rot+Ischemia | |
| VLeak | 164.9±9.8 | 131.35±5.43 | 113.6±8.3 | 128.39±30.25 |
| VADP | 857.1±40.1 | 568.16±64.89 | 222.8±25.6 | 231.76±66.41 |
| VADP | 534.8±13.5 | 422.92±51.02 | 164.8±11.5 | 200.11±57.51 |
| VAtr | 318.5±9.5 | 272.04±28.99 | 156.1±11.5 | 194.79±58.40 |
- p<0.001,
- p<0.01,
- p<0.05, if compared to control;
- p<0.05, if compared to 120 min ischemia group. Means ± standard errors of 3–7 separate experiments are presented.
Fig. 2Typical traces of respirometric recording of cortex mitochondria Additions: MT – mitochondria (0.25 mg protein/mL) in the presence of pyruvate/malate (1/1 mM); ADP – 2 mM; AM – 1.5 mM amytal; SUCC – 5 mM succinate; ATR – 100 μM atractyloside. A trace indicates oxygen concentration (nmol/ml), B – oxygen flux (pmol O2/(s˟ml).
Fig. 3Effect of rotenone intravenous infusion on complex I activity of cortex (A) and cerebellum (B) control and ischemia damaged mitochondria * – p<0.05, *** – p<0.01, if compared to control. Means±standard errors of 3–8 separate experiments are presented.
Fig. 4Effect of rotenone intravenous infusion on complex II activity of cortex (A) and cerebellum (B) control and ischemia damaged mitochondria Means±standard errors of 3 separate experiments are presented.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |